Esthesioneuroblastome : dilemme diagnostic et challenge therapeutique

Introduction : L’esthésioneuroblastome est une tumeur maligne rare des fosses nasales. Il s’agit d’une tumeur agressive et récidivante dont le traitement est controversé. Notre objectif est de décrire les particularités diagnostiques et les actualités thérapeutiques de cette tumeur.Matériels et méthode : Etude rétrospective sur une période de 10 ans (2001-2010), ayant intéressé trois cas d’esthésioneuroblastome colligés dans notre service.Résultats : Il s’agit de 3 patients âgés respectivement de 23, 30, 85 ans. Les signes fonctionnels sont l’obstruction nasale, l’épistaxis et les céphalées. L’endoscopie nasale a trouvé un processus tumoral endonasal dans tous les cas. Des adénopathies cervicales ont été retrouvées dans un cas. Le scanner du massif facial et la biopsie tumorale, réalisés dans les trois cas, ont permis de classer la tumeur respectivement aux stades B, C, A, selon la classification de KADISH. L’association chirurgie- radiothérapie a été préconisée dans deux cas et chimio-radiothérapie dans un cas. L’évolution a été favorable dans 2 cas. Le troisième patient a été perdu de vue.Discussion : le diagnostic d’esthesioneuroblastome est souvent tardif. L’imagerie est indispensable pour l’orientation de la stratégie thérapeutique. L’association chirurgie radiothérapie constitue le traitement de référence. La chimiothérapie gagne de plus en plus d’intérêt.Mots Clés: Esthésioneuroblastome; traitement; chirurgie; radiotherapie; chimiotherapie; pronosticIntroduction : Esthesioneuroblastoma is a rare malignant tumor of the nasal cavity. It is an aggressive tumor, associated with a high level of recurrence. Treatment is still controversial. The object of our report is to describe the clinical presentations and new therapeutic approaches of this tumor.Material and methods : We retrospectively reviewed three patients with nasosinusal esthesioneuroblastoma who were managed during a period of 10 years (2001- 2010).Results : the three patients were aged respectively of 23, 30 and 85 years. Functional signs were mainly nasal obstruction, epistaxis and headache. Nasal endoscopy found an endonasal tumor process in all cases. Cervical lymph nodes were noted in one case. The CT scann and the tumor biopsy were performed in all three cases. Esthesioneuroblastoma was classified, respectively in stage B, C and A, according to KADISH classification. The association surgery-radiotherapy has been advocated in both cases and chemo-radiotherapy in one case. The outcome was favorable in two cases. The third patient was lost to view.Discussion : The ENB is a rare neuroepithelial cancer of the nasal cavity. Its diagnosis is often delayed due to its nonspecific clinical presentation. Radiography is of a great contribution for the diagnosis and for guiding the therapeutic strategy. Surgery and radiotherapy are currently the recommended treatment modality. Chimiotherapy is a new therapeutic approach.Key Words : Esthesioneuroblastoma; treatement; surgery; radiotherapy; chimiotherapy prognosis

Minimally invasive total knee replacement : techniques and results

In this review, we outlined the definition of minimally invasive surgery (MIS) in total knee replacement (TKR) and described the different surgical approaches reported in the literature. Afterwards we went through the most recent studies assessing MIS TKR. Next, we searched for potential limitations of MIS knee replacement and tried to answer the following questions: Are there selective criteria and specific patient selection for MIS knee surgery? If there are, then what are they? After all, a discussion and conclusion completed this article. There is certainly room for MIS or at least less invasive surgery (LIS) for appropriate selected patients. Nonetheless, there are differences between approaches. Mini medial parapatellar is easy to master, quick to perform and potentially extendable, whereas mini subvastus and mini midvastus are trickier and require more caution related to risk of hematoma and VMO nerve damage. Current evidence on the safety and efficacy of mini-incision surgery for TKR does not appear fully adequate for the procedure to be used without special arrangements for consent and for audit or continuing research. There is an argument that a sudden jump from standard TKR to MIS TKR, especially without computer assistance such as navigation, patient specific instrumentation (PSI) or robotic, may breach a surgeon's duty of care toward patients because it exposes patients to unnecessary risks. As a final point, more evidence is required on the long-term safety and efficacy of this procedure which will give objective shed light on real benefits of MIS TKR